Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Assessing the effect of patient to provider language discordance on depression screening utilizing the Patient Health Questionnaire: an epidemiology study.

Murillo LA, Grekoff GA, Sheffield JC.

Fam Pract. 2019 Jan 25;36(1):27-31. doi: 10.1093/fampra/cmy097.

PMID:
30299462
2.

Intraoperative radiation therapy, opportunities for clinical practice normalization: MEDTING, a scientific platform.

Calvo FA, Murillo LA, Sallabanda M, Martinez-Villanueva J, Herranz R, Sole CV.

Rep Pract Oncol Radiother. 2013 Sep 28;19(4):253-8. doi: 10.1016/j.rpor.2013.08.009. eCollection 2014 Jul.

3.

Intraoperative radiation therapy opportunities for clinical practice normalization: Data recording and innovative development.

Calvo FA, Sallabanda M, Sole CV, Gonzalez C, Murillo LA, Martinez-Villanueva J, Santos JA, Serrano J, Alavrez A, Blanco J, Calin A, Gomez-Espi M, Lozano M, Herranz R.

Rep Pract Oncol Radiother. 2013 Aug 13;19(4):246-52. doi: 10.1016/j.rpor.2013.07.010. eCollection 2014 Jul.

4.

Global screening of potential Candida albicans biofilm-related transcription factors via network comparison.

Wang YC, Lan CY, Hsieh WP, Murillo LA, Agabian N, Chen BS.

BMC Bioinformatics. 2010 Jan 26;11:53. doi: 10.1186/1471-2105-11-53.

5.

Fungicidal activity of a phospholipase-A2-derived synthetic peptide variant against Candida albicans.

Murillo LA, Lan CY, Agabian NM, Larios S, Lomonte B.

Rev Esp Quimioter. 2007 Sep;20(3):330-3.

6.

Genome-wide transcription profiling of the early phase of biofilm formation by Candida albicans.

Murillo LA, Newport G, Lan CY, Habelitz S, Dungan J, Agabian NM.

Eukaryot Cell. 2005 Sep;4(9):1562-73.

7.

Regulatory networks affected by iron availability in Candida albicans.

Lan CY, Rodarte G, Murillo LA, Jones T, Davis RW, Dungan J, Newport G, Agabian N.

Mol Microbiol. 2004 Sep;53(5):1451-69.

8.

Mtp-40 and alpha antigen gene fragment amplification for the detection of Mycobacterium tuberculosis in Colombian clinical specimens.

Alfonso R, Romero RE, Patarroyo ME, Murillo LA.

Mem Inst Oswaldo Cruz. 2002 Dec;97(8):1157-63. Epub 2003 Jan 20.

9.

Identification, cloning, and sequencing of different cytokine genes in four species of owl monkey.

Hernández EC, Suárez CF, Méndez JA, Echeverry SJ, Murillo LA, Patarroyo ME.

Immunogenetics. 2002 Dec;54(9):645-53. Epub 2002 Nov 14.

PMID:
12466897
10.

Metabolic specialization associated with phenotypic switching in Candidaalbicans.

Lan CY, Newport G, Murillo LA, Jones T, Scherer S, Davis RW, Agabian N.

Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):14907-12. Epub 2002 Oct 23.

11.

Identification of a differentially expressed mRNA in axenic Leishmania panamensis amastigotes.

Gutiérrez JA, Puentes F, Moreno A, Patarroyo ME, Murillo LA.

Mem Inst Oswaldo Cruz. 2001 Aug;96(6):835-8.

12.

Plasmodium vivax: polymorphism in the merozoite surface protein 1 gene from wild Colombian isolates.

Gutierrez A, Vicini J, Patarroyo ME, Murillo LA, Patarroyo MA.

Exp Parasitol. 2000 Jul;95(3):215-9.

PMID:
10964650
13.

Plasmodium falciparum: polymorphism in regions II and III of the knob-associated histidine-rich protein gene from two areas of different endemicity.

Mayor AG, Trujillo E, Roca A, Tanner M, Mshinda H, Patarroyo ME, Alonso PL, Murillo LA.

Exp Parasitol. 2000 Apr;94(4):264-8. No abstract available.

PMID:
10831395
14.

Isolation, characterization, molecular cloning and amplification of a species-specific M. leprae antigen.

Soto CY, Moreno PA, Valencia JT, Bernal MM, Guzman F, Patarroyo ME, Murillo LA.

Int J Lepr Other Mycobact Dis. 1999 Dec;67(4):392-402.

PMID:
10700913
15.

Leishmania panamensis: a 44bp deletion in gp63 gene is found in cDNA and genomic libraries.

Hoya RD, Trujillo CE, Cardenas C, Puentes F, Patarroyo ME, Murillo LA.

Mem Inst Oswaldo Cruz. 1999 Sep-Oct;94(5):641-3. No abstract available.

16.

Identification of Mycobacterium bovis in bovine clinical samples by PCR species-specific primers.

Romero RE, Garzón DL, Mejía GA, Monroy W, Patarroyo ME, Murillo LA.

Can J Vet Res. 1999 Apr;63(2):101-6.

17.

Sequence of the cry11Bb11 gene from Bacillus thuringiensis subsp. medellin and toxicity analysis of its encoded protein.

Orduz S, Realpe M, Arango R, Murillo LA, Delécluse A.

Biochim Biophys Acta. 1998 Oct 14;1388(1):267-72.

PMID:
9774743
18.

Genetic restriction in two conserved regions of Plasmodium falciparum EBA-1751t.

Carrillo EF, Patarroyo MA, Patarroyo ME, Murillo LA.

Mol Biochem Parasitol. 1997 Apr;85(2):255-8. No abstract available.

PMID:
9106198
19.

Genetic polymorphism of the Duffy receptor binding domain of Plasmodium vivax in Colombian wild isolates.

Ampudia E, Patarroyo MA, Patarroyo ME, Murillo LA.

Mol Biochem Parasitol. 1996 Jun;78(1-2):269-72. No abstract available.

PMID:
8813697
20.
21.

Species-specific identification of Mycobacterium bovis by PCR.

Rodriguez JG, Mejia GA, Del Portillo P, Patarroyo ME, Murillo LA.

Microbiology. 1995 Sep;141 ( Pt 9):2131-8.

PMID:
7496524
22.

Vaccination with SPf66, a chemically synthesised vaccine, against Plasmodium falciparum malaria in Colombia.

Valero MV, Amador LR, Galindo C, Figueroa J, Bello MS, Murillo LA, Mora AL, Patarroyo G, Rocha CL, Rojas M, et al.

Lancet. 1993 Mar 20;341(8847):705-10.

PMID:
8095622
23.

Safety and immunogenicity of the synthetic malaria vaccine SPf66 in a large field trial.

Amador R, Moreno A, Murillo LA, Sierra O, Saavedra D, Rojas M, Mora AL, Rocha CL, Alvarado F, Falla JC, et al.

J Infect Dis. 1992 Jul;166(1):139-44.

PMID:
1607685
24.

Study of the safety and immunogenicity of the synthetic malaria SPf66 vaccine in children aged 1-14 years.

Patarroyo G, Franco L, Amador R, Murillo LA, Rocha CL, Rojas M, Patarroyo ME.

Vaccine. 1992;10(3):175-8.

PMID:
1557933
25.

Determination of the immunization schedule for field trials with the synthetic malaria vaccine SPf 66.

Rocha CL, Murillo LA, Mora AL, Rojas M, Franco L, Cote J, Valero MV, Moreno A, Amador R, Nuñez F, et al.

Parasite Immunol. 1992 Jan;14(1):95-109.

PMID:
1557233
26.

A specific T-cell receptor genotype preference in the immune response to a synthetic Plasmodium falciparum malaria vaccine.

Murillo LA, Tenjo FA, Clavijo OP, Orozco MA, Sampaio S, Kalil J, Patarroyo ME.

Parasite Immunol. 1992 Jan;14(1):87-94.

PMID:
1532634
27.

Amplification of a species-specific DNA fragment of Mycobacterium tuberculosis and its possible use in diagnosis.

Del Portillo P, Murillo LA, Patarroyo ME.

J Clin Microbiol. 1991 Oct;29(10):2163-8.

28.

Molecular analysis of HLA DR4-beta 1 gene in malaria vaccinees. Typing and subtyping by PCR technique and oligonucleotides.

Murillo LA, Rocha CL, Mora AL, Kalil J, Goldenberg AK, Patarroyo ME.

Parasite Immunol. 1991 Mar;13(2):201-10.

PMID:
2052406
29.

A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria.

Patarroyo ME, Amador R, Clavijo P, Moreno A, Guzman F, Romero P, Tascon R, Franco A, Murillo LA, Ponton G, et al.

Nature. 1988 Mar 10;332(6160):158-61.

PMID:
2450281

Supplemental Content

Loading ...
Support Center